Switzerland· 58325002
Ecalta 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
A anidulafungin product, registered in Switzerland by Pfizer AG and dispensed under Swissmedic category A. The same ATC class is registered in 16 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Anidulafungin is registered in 16 of 19 countries.
Countries holding a registration under ATC J02AX06 (anidulafungin), each read from that country’s own register.
- This record: Switzerland
- 9 of them publish a price we can compare per daily dose
Anidulafungin · ATC J02AX06
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of anidulafungin costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- Switzerland: $460.55 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Anidulafungin · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$460.55
The record
At a glance
- Manufacturer
- Pfizer AG
- Country
- Switzerland (CH)
- ATC code
- J02AX06
- ATC class
- Anidulafungin
- Defined daily dose
- 0.1 g, P
- Swissmedic category
- A
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for anidulafungin.
Graded by severity as the source publishes them — 1 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Anidulafungin · interactions on record
1 record
Same class
Other records under J02AX06
Anidulafungin, as other registers publish it.
- DenmarkAnidulafungin "Accord"Accord Healthcare B.V.
- DenmarkAnidulafungin "Hikma"Hikma Farmacêutica (Portugal) S.A.
- DenmarkAnidulafungin "Reig Jofre"Bioglan AB
- DenmarkAnidulafungin "Sandoz"Sandoz A/S
- DenmarkAnidulafungin "Stada"STADA Arzneimittel AG
- IrelandAnidulafungin 100 mg powder for concentrate for solution for infusionAccord Healthcare Ireland Ltd.
- IrelandAnidulafungin 100 mg Powder for concentrate for solution for infusionRowex Limited,
- United KingdomAnidulafungin 100mg powder for concentrate for solution for infusion vialsTeva UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e8bd1aae-1ac6-402d-a683-a0f5bf7fdd69 GET /v1/drugs/e8bd1aae-1ac6-402d-a683-a0f5bf7fdd69?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about anidulafungin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.